# Rameda plans to launch new drugs and expand production capacity

Rameda plans to produce new drugs for digestive system, diabetes, nerves, and antibiotics in 2020, and has added production lines including sterile plastic ampoules BFS, raising capacity from 35 million to 144 million ampoules per year.

- Type: Expansion
- Announced: 2019-12-08
- Where: Egypt
- Starts operating: Apr 2019
- Status: completed
- Capacity: 144 million ampoules per year
- Products: drugs for digestive system, diabetes treatments, neurological drugs, antibiotics, supplements

## Companies

- [Tenth of Ramadan Company for Pharmaceutical Industries and Diagnostic Products (Rameda)](https://endata.com/companies/43796.md)

## Sources

- [zawya.com](https://www.zawya.com/en/business/egypts-rameda-plans-to-introduce-new-drugs-for-the-digestive-system-diabetes-nerves-and-antibiotics-jwgye3v2), 2019-12-08: "The company’s CEO Amr Morsi said that they are currently focusing on launching new products and registering others to increase the market share"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.